A pharmaceutical company popular with retail investors.
AI-generated insights about Galt Pharmaceuticals from various financial sources
The speaker is short the stock, as it was mentioned in a list of his current short positions.
Viewed as an attractive short target due to its popularity with retail investors, whom the speaker believes will eventually lose money, making it a stock they are 'excited to short it again'.
The speaker is short the stock, as it was mentioned in a list of his current short positions.
Viewed as an attractive short target due to its popularity with retail investors, whom the speaker believes will eventually lose money, making it a stock they are 'excited to short it again'.